Zhang, Y., Sun, B., Hu, M., Lou, Y., Lu, J., Zhang, X., . . . Han, B. (2020). CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients. Front Oncol.
Chicago Style CitationZhang, Yanwei, et al. "CXCL9 As a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients." Front Oncol 2020.
MLA CitationZhang, Yanwei, et al. "CXCL9 As a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients." Front Oncol 2020.
Warning: These citations may not always be 100% accurate.